Cicek, E. Et Al. 2022. EGF-SNX3-EGFR axis drives tumor progression and metastasis in triple-negative breast cancers. Oncogene , vol.41, no.2 , 220-232.

Cicek, E., Circir, A., Oyken, M., Akbulut Caliskan, O., Dioken, D. N., Guntekin Ergun, S., ... Cetin-Atalay, R.(2022). EGF-SNX3-EGFR axis drives tumor progression and metastasis in triple-negative breast cancers. Oncogene , vol.41, no.2, 220-232.

Cicek, Esra Et Al. "EGF-SNX3-EGFR axis drives tumor progression and metastasis in triple-negative breast cancers," Oncogene , vol.41, no.2, 220-232, 2022

Cicek, Esra Et Al. "EGF-SNX3-EGFR axis drives tumor progression and metastasis in triple-negative breast cancers." Oncogene , vol.41, no.2, pp.220-232, 2022

Cicek, E. Et Al. (2022) . "EGF-SNX3-EGFR axis drives tumor progression and metastasis in triple-negative breast cancers." Oncogene , vol.41, no.2, pp.220-232.

@article{article, author={Esra Cicek Et Al. }, title={EGF-SNX3-EGFR axis drives tumor progression and metastasis in triple-negative breast cancers}, journal={Oncogene}, year=2022, pages={220-232} }